JPRN-UMIN000015247
Completed
未知
Efficacy and safety of daclatasvir and asunaprevir in patients with chronic hepatitis C - Efficacy and safety of daclatasvir and asunaprevir
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 sites350 target enrollmentSeptember 25, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with chronic hepatitis C virus infection
- Sponsor
- Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Co\-infection with hepatitis B virus 2\) Co\-infection with anti\-human immunodeficiency virus 3\) Other forms of liver disease (alcohol liver disease, autoimmune hepatitis etc.) 4\) Decompensated cirrhosis, Liver failure 5\) Severe multisystem disease, Severe immunodeficiency 6\) Pregnant woman 7\) Contraindication to daclatasvir and asunaprevir
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000016181shonan kamakura general hospital30
Completed
Not Applicable
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infectiohemodialyzed patients with genotype 1 chronic hepatitis C infectionJPRN-UMIN000024227others130
Completed
Not Applicable
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis Chemodialyzed patients with chronic hepatitis CJPRN-UMIN000016355Hokkaido University Hospital100
Unknown
Phase 4
Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis CHepatitis C, ChronicNCT02639585Pusan National University Hospital32
Recruiting
Not Applicable
Evaluation of the efficacy of daclatasvir+asunaprevir+beclabuvir for Japanese hepatitis C patients; a prospective study in real life settings.JPRN-UMIN000026909Toranomon Hospital100